An Open-Label, Single-Centre,Two Part Phase I Mass Balance Study to Assess the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of Orally Administered [14C]-TAK-385 in Healthy Male Subjects
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009885/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this 2 part study is to look at how TAK-385 is taken up, broken down and
removed from the body when given as a radiolabelled oral solution (by mouth) or as an oral
tablet (by mouth) followed by a radiolabelled intravenous (IV) infusion (into the arm vein).
提供机构：
Vivli
创建时间：
2024-03-14
